The steady increase of new drugs of abuse on the illicit drug market is a great challenge for analytical toxicologists. Because most of these new drugs or ... MR Meyer,FT Peters - 《Therapeutic Drug Monitoring》 被引量: 94发表: 2012年 New sources of drugs for hematologic malignancies Advanc...
No, I don't think we have my name is li Xiao, my name is Fred Smith. Jimmy practice medicine hi, miss Watson a pleasure to meet you. Jack she is from England. Yes, I think we have met before. It's good to see you again. That's right. Mister li. Mister Fred Miller. Our ma...
There's another sign that we need pit crews, and that's the unmanageable cost of our care. Now we in medicine, I think, are baffled by this question of cost. We want to say, "This is just the way it is. This is just what medicine requires." When you go from a world where you...
Burton, Thomas. 1996. How a yogurt company developed a new cancer drug. TheWall Street Journal, Wednesday, July 17.Burton, Thomas. 1996. How a yogurt company developed a new cancer drug. The Wall Street Journal, Wednesday, July 17.
Biosimilars, which are highly similar versions of complex biologic drugs, present a new challenge in the realm of drug patents. The approval process for biosimilars is more complex than that for traditional generics, potentially extending the effective monopoly of original biologic drugs. Regulatory Lan...
Much of the existing research on mortality rates in astronauts has not yet explored the mental and physical demands of this job. There also has not been a lot of research on whether astronauts show what is known as the "healthy worker effect". This effect leads people with employment of any...
A biosimilar is not considered a “generic” in the same way that a traditional, small molecule drug (for example: ibuprofen or acetaminophen) is determined to be a generic. Biosimilars are "similar" because they are biologics that do not have to be exact copies of the active ingredient, as...
However, true validation of any a new molecular target in human disease is challenging before a drug can be successfully developed since biological discrepancy among in vitro, in disease animal model, and human disease may hinder the true validation of the molecular target's function8, 9, 10, ...
WeightWatchers jumps into the prescription weight loss drug business In addition, these are injection medications. As such, there could also be pain, swelling and redness at the injection site. And because these medications are relatively new, long-term effects are not known, and it is also ...
To answer the above questions, this paper constructs a Stackelberg game model consisting of a manufacturer (leader) and a retailer (follower). In the game, the manufacturer produces both brown and green products, and the green product is sold to the final consumer through two channel structures...